Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elda Favari

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Cell Reports|April 7, 2016
An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive CycleSara Della Torre, Nico Mitro, Roberta Fontana, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolismNicoletta Ronda, Daniela Greco, Maria Pia Adorni, et al.
Circulation. Cardiovascular Genetics|November 9, 2011
Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3Livia Pisciotta, Elda Favari, Lucia Magnolo, et al.
Biomedicines|December 23, 2020
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)Alessia Di Costanzo, Annalisa Ronca, Laura D'Erasmo, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2023
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitorsFabiana Perrone, Elda Favari, Giuseppe Maglietta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 18, 2022
High-Density Lipoprotein and Long-Term Incidence and Progression of Aortic Valve Calcification: The Multi-Ethnic Study of AtherosclerosisAnna E Bortnick, Petra Buzkova, James D Otvos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 11, 2024
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint InhibitorsGiulia Mazzaschi, Fabiana Perrone, Giuseppe Maglietta, et al.
Journal of Clinical Lipidology|July 29, 2020
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a)Claudia Stefanutti, Livia Pisciotta, Elda Favari, et al.
Molecular Genetics and Metabolism|September 11, 2012
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiencyTommaso Fasano, Paolo Zanoni, Claudio Rabacchi, et al.
The Oncologist|October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort StudyFederica Pecci, Luca Cantini, Valeria Cognigni, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Cell Reports|April 7, 2016
An Essential Role for Liver ERα in Coupling Hepatic Metabolism to the Reproductive CycleSara Della Torre, Nico Mitro, Roberta Fontana, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 22, 2015
Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolismNicoletta Ronda, Daniela Greco, Maria Pia Adorni, et al.
Circulation. Cardiovascular Genetics|November 9, 2011
Characterization of three kindreds with familial combined hypolipidemia caused by loss-of-function mutations of ANGPTL3Livia Pisciotta, Elda Favari, Lucia Magnolo, et al.
Biomedicines|December 23, 2020
HDL-Mediated Cholesterol Efflux and Plasma Loading Capacities Are Altered in Subjects with Metabolically- but Not Genetically Driven Non-Alcoholic Fatty Liver Disease (NAFLD)Alessia Di Costanzo, Annalisa Ronca, Laura D'Erasmo, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2023
The role of blood cholesterol quality in patients with advanced cancer receiving immune checkpoint inhibitorsFabiana Perrone, Elda Favari, Giuseppe Maglietta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 18, 2022
High-Density Lipoprotein and Long-Term Incidence and Progression of Aortic Valve Calcification: The Multi-Ethnic Study of AtherosclerosisAnna E Bortnick, Petra Buzkova, James D Otvos, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 11, 2024
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint InhibitorsGiulia Mazzaschi, Fabiana Perrone, Giuseppe Maglietta, et al.
Journal of Clinical Lipidology|July 29, 2020
Lipoprotein(a) concentration, genetic variants, apo(a) isoform size, and cellular cholesterol efflux in patients with elevated Lp(a) and coronary heart disease submitted or not to lipoprotein apheresis: An Italian case-control multicenter study on Lp(a)Claudia Stefanutti, Livia Pisciotta, Elda Favari, et al.
Molecular Genetics and Metabolism|September 11, 2012
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiencyTommaso Fasano, Paolo Zanoni, Claudio Rabacchi, et al.
The Oncologist|October 5, 2023
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort StudyFederica Pecci, Luca Cantini, Valeria Cognigni, et al.
Pageof 6